Lithium Toxicity: Clinical Presentation, Side Effects, and Management
Clinical Presentation of Lithium Toxicity
Lithium toxicity is closely related to serum concentrations, with toxicity risk beginning at 1.5 mEq/L and serious toxicity at levels >2.0 mEq/L, though sensitive patients may exhibit toxic signs even below 1.5 mEq/L. 1, 2
Early/Mild Toxicity (levels <2.0 mEq/L):
- Gastrointestinal symptoms: Diarrhea, nausea, vomiting 3, 2
- Neuromuscular signs: Fine hand tremor, muscular weakness, lack of coordination 2
- Renal manifestations: Polyuria-polydipsia 3, 2
- Drowsiness and general discomfort 2
Moderate Toxicity (levels 2.0-3.0 mEq/L):
- Giddiness and ataxia 2
- Blurred vision and tinnitus 2
- Large output of dilute urine 2
- Slurred speech and confusion 2
Severe Toxicity (levels >3.0 mEq/L):
- Neurological: Seizures, stupor, coma, somnolence, psychomotor retardation, incontinence 2
- Cardiovascular: Arrhythmias (including severe bradycardia and sinus node dysfunction), hypotension, peripheral circulatory collapse 3, 2, 4
- Complex multi-organ involvement affecting multiple organ systems 2
Critical distinction: Patients with chronic toxicity (developing during maintenance therapy) typically present with more severe symptoms compared to acute overdose patients, even at similar serum levels. 5 In acute intoxication, patients may have mild symptoms despite potentially lethal levels (≥3.5 mEq/L). 5
Adverse Effects and Side Effects
Cardiovascular Effects:
- Cardiac arrhythmias, including severe bradycardia requiring pacemaker placement 3, 4
- ECG changes: T-wave flattening/inversion, QT prolongation, PR interval prolongation, sinoatrial block 2, 4
- Hypotension and syncope 2, 4
- Sinus node dysfunction 2, 4
Neurological Effects:
- Tremor, muscle fasciculations, twitching, clonic movements 2
- Ataxia, choreo-athetotic movements, hyperactive deep tendon reflexes 2
- Seizures, blackout spells, vertigo, dizziness 2
- Acute dystonia, downbeat nystagmus 2
- Pseudotumor cerebri (increased intracranial pressure) which can lead to blindness if undetected 2
Renal Effects:
- Nephrogenic diabetes insipidus (polyuria, polydipsia) 3, 6
- Acute renal failure, particularly with volume depletion 7
- Albuminuria, oliguria, glycosuria 2
Endocrine Effects:
Dermatologic Effects:
Other Effects:
Treatment of Lithium Toxicity
Immediate Management Based on Severity:
Mild Toxicity (levels <2.0 mEq/L with minimal symptoms):
- Discontinue or reduce lithium dose 2, 8
- Resume treatment at lower dose after 24-48 hours 2
- Ensure adequate hydration 3
- Monitor serum lithium levels, electrolytes, and renal function 3
Moderate to Severe Toxicity:
Discontinue lithium immediately 2
Supportive care:
Gastric decontamination (if recent ingestion):
Enhanced elimination:
Hemodialysis Indications:
Hemodialysis is the definitive treatment for severe lithium toxicity and should be initiated urgently in the following situations: 3
- Serum lithium ≥3.5 mEq/L with significant neurological or cardiovascular symptoms 3
- Any lithium level with significant cardiovascular compromise: symptomatic bradycardia, advanced AV block, refractory hypotension 3
- Severe neurological symptoms (confusion, seizures, coma) regardless of level in chronic toxicity 5
- Refractory toxicity despite conservative management 3
Hemodialysis technique:
- Use high-flux membranes with bicarbonate dialysate for optimal lithium removal 7
- Continue dialysis until level <1.0 mEq/L is achieved 3
- Measure lithium level 4-6 hours post-dialysis to evaluate for rebound (redistribution from tissues) 3
- Duration typically 6-8 hours, but may require consecutive sessions 3, 7
Important caveat: In acute overdose with levels ≥3.5 mEq/L but mild symptoms, hemodialysis may not be necessary. 5 These patients often recover without dialysis or permanent sequelae. 5 However, patients with chronic toxicity and severe symptoms should receive hemodialysis even with lower levels. 5
Management of Specific Complications:
Cardiovascular complications:
- For arrhythmias: Correct electrolytes and proceed with hemodialysis 3
- Avoid antiarrhythmic drugs that prolong QT interval (amiodarone, sotalol) if QT prolongation present 3
- For hypotension: IV fluids and vasopressors (norepinephrine); urgent hemodialysis if refractory 3
Renal support:
- Hemodialysis addresses both toxicity and acute renal failure 7
- Volume repletion for dehydration-induced renal impairment 7
Prevention of Future Toxicity:
- Evaluate and address precipitating factors: dehydration, medication interactions (especially NSAIDs), renal impairment 3
- Temporarily suspend lithium during intercurrent illness, IV radiocontrast administration, bowel preparation, or prior to major surgery 3
- Avoid concomitant NSAIDs which increase lithium levels 1, 3
- Educate patients about early warning signs: fatigue, reduced urine output, dizziness, muscle weakness, diarrhea, vomiting, excessive sweating 1
- Increase fluid intake by 0.5-1 L during hot weather (beyond standard 2.5-3 L daily) 1
- Regular monitoring: lithium levels, electrolytes, renal function, thyroid function every 3-6 months once stable 9
Common Pitfalls to Avoid:
- Do not rely solely on serum lithium levels to determine severity in chronic toxicity - clinical symptoms are more important 5, 6
- Do not use activated charcoal - it is ineffective for lithium 1
- Do not delay hemodialysis in patients with severe symptoms and chronic toxicity, even if levels are <3.5 mEq/L 5
- Monitor for post-dialysis rebound - lithium redistributes from tissues, requiring level checks 4-6 hours after dialysis 3
- Recognize that cardiac manifestations are often overlooked but can be life-threatening 4